Data / Form D filings / Cadence Biomedical, Inc.
Cadence Biomedical, Inc.: Form D filings
Cadence Biomedical, Inc., a company in Seattle, WA, filed 6 Form D notices with the SEC between 2011 and 2016. The latest, on June 9, 2016, reports $102,686 sold of a $505,000 offering to 10 investors.
Find out what Cadence Biomedical, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 3534 BAGLEY AVENUE N, Seattle, WA, 98103
- Phone
- (206) 659-0614
- Industry
- Other
- Entity type
- Corporation
- Incorporated in
- Washington
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1533465
The full lists. Form D filings in Washington: 1,095 rows, $54.75, or the new rows each week for $19 a month. Form D filings in other industries: 9,873 rows, $178.73, or the new rows each week for $19.10 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 9, 2016 | Amendment | $505,000 | $102,686 | $402,314 | 10 | Mar 24, 2016 | sec.gov |
| Mar 29, 2016 | New notice | $325,000 | $22,686 | $302,314 | 6 | Mar 24, 2016 | sec.gov |
| Mar 24, 2015 | New notice | $1,300,000 | $959,578 | $340,422 | 26 | Mar 24, 2015 | sec.gov |
| Feb 28, 2013 | Amendment | $1,627,257 | $1,313,158 | $314,099 | 48 | Dec 27, 2011 | sec.gov |
| Jan 3, 2012 | New notice | $750,000 | $265,000 | $485,000 | 19 | Dec 27, 2011 | sec.gov |
| Oct 25, 2011 | New notice | $300,000 | $255,000 | $45,000 | 6 | Jul 22, 2011 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Michael Hovanes | Executive Officer, Director, Promoter | |
| Jason Schoen | Executive Officer | |
| Rob Lewis | Director | |
| Chie Kawahara | Executive Officer | |
| Brian Glaister | Executive Officer | |
| David Caro | Director | |
| George Saul | Director |
Other companies in Washington that filed recently
- SunFly Brands, Inc. $869,941 · Nov 9, 2026
- Legacy Venture Fund I, LLC $68 million · Nov 6, 2026
- NexLevel Cash Flow Holdings, LLC offering · Nov 3, 2026
- Awakened Grains LLC offering · Oct 28, 2026
- RBC Network Services Corp. $10 million · Oct 28, 2026
- Cliffview Power LLC $1,000 · Oct 27, 2026
- Harmony Apartments Opportunity Fund, LP $1.1 million · Oct 23, 2026
- WaveDivision Capital XIX, LLC $163 million · Oct 21, 2026
- Sports Innovation Group Inc. $975,000 · Oct 19, 2026
- Nordic 15 LLC offering · Oct 2, 2026
- ZIN BOATS, INC. offering · Sep 28, 2026
- Meadow AI, Inc. $13.1 million · Sep 25, 2026
- True Collective LLC $3.8 million · Sep 23, 2026
- Shoot 360 Inc. $4.8 million · Sep 21, 2026
- North40 Capital Growth Fund II LLC $100,000 · Sep 16, 2026
Every Form D from the week of Jun 6, 2016 · All recent filings in Washington · All recent Other filings
Read from SEC EDGAR. Amount sold is what Cadence Biomedical, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.